The firm believes its method, which involves multiplex ligation probes and sample barcoding, could significantly reduce assay costs and improve accuracy.

Individuals with germline PTEN mutations who have autism spectrum disorder or developmental delay often also have copy number variations, a new study has found.

Transcriptome profiles in ovarian cells from young and old non-human primates unearthed expression changes that coincided with flagging fertility in humans.

News items for the week of Jan. 27, 2020.

A new analysis finds that Neanderthal ancestry can be found across human populations, including among Africans.

Zimbabwe, facing drought and possible famine, lifts its ban and imports genetically modified corn, according to Bloomberg.

Researchers in South Africa are concerned that breeding experiments will lead to a loss of genetic diversity among key species there, according to the Guardian.

In Science this week: genetic mutation linked to schizophrenia among South African Xhosas, engineering the bee microbiome to address parasite and virus, and more.

The molecular assay detects and differentiates Trichomonas vaginalis and/or Mycoplasma genitalium in clinical urine samples.

Gladstone Institutes researchers will use proteomic, genomic, and gene-altering approaches to investigate apoe4 toxicity as part of a five-year project.

The company anticipates launching an in vitro diagnostic version of the 10-gene ThyroidPrint assay in South America and Europe after receiving regulatory clearance by Q2 2021.

The FDA has been prodding labs performing pharmacogenetic testing, and software firms providing reports from such testing, to undergo regulatory review.

RedShift BioAnalytics (RedShiftBio) , a provider of analytical solutions for protein characterization in biotherapeutic development, has appointed Julien Bradley as CEO. Bradley most recently served as vice president of marketing, corporate development and strategy at Quanterix, where he also previously served as VP of marketing and sales operations. He has also held senior roles at Phosphorus, OvaScience, and Thermo Fisher Scientific.

China remains a key strategic market for Roche, and it said that it has multiple assays for 2019-nCoV coronavirus for research-use only. 

Medicare Administrative Contractor Palmetto released its final local coverage decision last year, and WPSIC has now aligned its coverage.

The system showed good performance for cervical samples as well as orophyrengeal samples, and required no extraction step.

A new analysis has provided evidence that adjuvant lung cancer immunotherapy benefits those with lingering ctDNA, but not necessary those without.

The company, which recently signed a licensing agreement with Horizon Discovery, just raised $45 million in a Series B financing round.

Clinical sequencing consumables revenues grew 20 percent year over year and accounted for just over 40 percent of total consumables shipments in 2019.

The rise of new protein analysis techniques have some questioning whether mass spec will in coming years retain its dominant position within proteomics.

Researchers used a statistical approach to identify Neanderthal ancestry in thousands of individuals, refining estimates on the proportion of ancestry in various human populations.

The Chinese company has also granted the underwriters of the offering an option to purchase an additional 200,004 ADS to cover overallotments.

An analysis of cases and controls from South Africa's Xhosa population pointed to private, damaging mutations in genes expressed in the brain.